NSW Health has now updated its pharmacy trial guidelines after ophthalmologists picked up an error in identifying two types of herpes zoster. The department confirmed last week…
Ophthalmologists have pointed out an error in the NSW pharmacy trial prescribing guidelines — one that ends up confusing between two different manifestations of herpes…
Recombinant herpes zoster vaccine Shingrix carries a “very rare” risk of Guillain–Barre syndrome, the TGA says. The regulator says patients should be advised to seek…
Another 215,000 patients are now eligible for free shingles vaccination as the government assures GPs it has bought enough of the recombinant vaccine Shingrix to…
Monthly shingles vaccinations have soared from 30,000 to 200,000 since the National Immunisation Program replaced the live-attenuated Zostavax with recombinant vaccine Shingrix, data show. Until…
Adults who have received an indicated varicella vaccine should be eligible for the recombinant herpes zoster vaccine Shringrix, according to ATAGI. The Australian Immunisation Handbook…
The months-long shortage of the recombinant herpes zoster vaccine Shingrix has continued to frustrate GPs, who are being forced to ration doses and choose which…
The Queensland Government’s pharmacy prescribing experiment is finally a reality. Pharmacists in the pilot confirmed on Wednesday morning that the State Government had given them…
GPs say they have not received enough stock of recombinant herpes zoster vaccine Shingrix to meet patient demand after it was listed on the National…
The recombinant herpes zoster vaccine, Shingrix, will soon replace the live-attenuated vaccine, Zostavax, on the National Immunisation Program following advice from the PBAC and ATAGI,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
